• Something wrong with this record ?

Harnessing the combined effect of antivirulence agent trans-chalcone with bactericidal curcumin against sortase A enzyme to tackle Gram-positive bacterial infections

P. Kumari, SK. Banerjee, US. Murty, V. Ravichandiran, U. Mohan

. 2024 ; 69 (3) : 639-652. [pub] 20231106

Status minimal Language English Country Czech Republic

Document type Journal Article

Gram-positive bacteria are responsible for a wide range of infections in humans. In most Gram-positive bacteria, sortase A plays a significant role in attaching virulence factors to the bacteria's cell wall. These cell surface proteins play a significant role in virulence and pathogenesis. Even though antibiotics are available to treat these infections, there is a continuous search for an alternative strategy due to an increase in antibiotic resistance. Thus, using anti-sortase drugs to combat these bacterial infections may be a promising approach. Here, we describe a method for targeting Gram-positive bacterial infection by combining curcumin and trans-chalcone as sortase A inhibitors. We have used curcumin and trans-chalcone alone and in combination as a sortase A inhibitor. We have seen ~78%, ~43%, and ~94% inhibition when treated with curcumin, trans-chalcone, and a combination of both compounds, respectively. The compounds have also shown a significant effect on biofilm formation, IgG binding, protein A recruitment, and IgG deposition. We discovered that combining curcumin and trans-chalcone is more effective against Gram-positive bacteria than either compound alone. The present work demonstrated that a combination of these natural compounds could be used as an antivirulence therapy against Gram-positive bacterial infection.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24009814
003      
CZ-PrNML
005      
20240606085139.0
007      
ta
008      
240606s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-023-01097-1 $2 doi
035    __
$a (PubMed)37930610
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kumari, Poonam $u Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, 781101, India
245    10
$a Harnessing the combined effect of antivirulence agent trans-chalcone with bactericidal curcumin against sortase A enzyme to tackle Gram-positive bacterial infections / $c P. Kumari, SK. Banerjee, US. Murty, V. Ravichandiran, U. Mohan
520    9_
$a Gram-positive bacteria are responsible for a wide range of infections in humans. In most Gram-positive bacteria, sortase A plays a significant role in attaching virulence factors to the bacteria's cell wall. These cell surface proteins play a significant role in virulence and pathogenesis. Even though antibiotics are available to treat these infections, there is a continuous search for an alternative strategy due to an increase in antibiotic resistance. Thus, using anti-sortase drugs to combat these bacterial infections may be a promising approach. Here, we describe a method for targeting Gram-positive bacterial infection by combining curcumin and trans-chalcone as sortase A inhibitors. We have used curcumin and trans-chalcone alone and in combination as a sortase A inhibitor. We have seen ~78%, ~43%, and ~94% inhibition when treated with curcumin, trans-chalcone, and a combination of both compounds, respectively. The compounds have also shown a significant effect on biofilm formation, IgG binding, protein A recruitment, and IgG deposition. We discovered that combining curcumin and trans-chalcone is more effective against Gram-positive bacteria than either compound alone. The present work demonstrated that a combination of these natural compounds could be used as an antivirulence therapy against Gram-positive bacterial infection.
650    12
$a kurkumin $x farmakologie $x chemie $7 D003474
650    12
$a cysteinové endopeptidasy $x metabolismus $7 D003546
650    12
$a aminoacyltransferasy $x antagonisté a inhibitory $x metabolismus $7 D019881
650    12
$a bakteriální proteiny $x metabolismus $x antagonisté a inhibitory $7 D001426
650    12
$a antibakteriální látky $x farmakologie $x chemie $7 D000900
650    12
$a biofilmy $x účinky léků $7 D018441
650    _2
$a lidé $7 D006801
650    12
$a chalkon $x farmakologie $x chemie $7 D002599
650    _2
$a grampozitivní bakterie $x účinky léků $7 D006094
650    _2
$a grampozitivní bakteriální infekce $x farmakoterapie $x mikrobiologie $7 D016908
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a zvířata $7 D000818
650    _2
$a virulence $x účinky léků $7 D014774
650    _2
$a faktory virulence $x metabolismus $7 D037521
655    _2
$a časopisecké články $7 D016428
700    1_
$a Banerjee, Sanjay K $u Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, 781101, India
700    1_
$a Murty, Upadhyayula Surayanarayana $u Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, 781101, India
700    1_
$a Ravichandiran, Velayutham $u Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, 700054, India
700    1_
$a Mohan, Utpal $u Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, 700054, India. mohan.utpal@gmail.com $1 https://orcid.org/0000000202567305
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 69, č. 3 (2024), s. 639-652
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37930610 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240606 $b ABA008
991    __
$a 20240606085133 $b ABA008
999    __
$a min $b bmc $g 2102565 $s 1219644
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 69 $c 3 $d 639-652 $e 20231106 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
LZP    __
$a Pubmed-20240606

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...